Deloitte Leaders to Discuss AI in Pharmacovigilance at Xtalks Webinar
Deloitte executives will present on leveraging AI to enhance pharmacovigilance processes in an upcoming Xtalks webinar. The session will focus on practical applications and maintaining human oversight.
Companies in the pharmaceutical and life sciences sectors are facing increasing volumes of data for pharmacovigilance, prompting a need for more efficient case intake processes. Deloitte Consulting LLP leaders will address how artificial intelligence (AI) can be integrated to manage this data effectively in a webinar hosted by Xtalks on October 28, 2026.
The session aims to demonstrate practical approaches to applying AI in regulated pharmacovigilance environments. Key areas to be covered include automated case intake, quality controls, confidence indicators, auditability, and the crucial role of human oversight. The goal is to augment existing processes, allowing expert attention to be focused where it adds the most value.
A live demonstration of Deloitte's ElevateSafety™ and Detective tools, powered by Converge™ by Deloitte, will illustrate how AI can detect, structure, and route adverse event information from diverse sources. This will provide attendees with a tangible view of current AI capabilities for safety operations.
The webinar is scheduled for 1:00 PM EDT (10:00 AM PDT). It is designed for pharmacovigilance teams seeking to manage growing data streams without compromising quality, compliance, or accountability. Cyle Connell and Ellen O'Dea from Deloitte Consulting LLP will lead the presentation.